Metformin is Protective Against the Development of Mood Disorders

Discussion These results provide proof-of-principle of combining gene
expression signature technology with pharmacoepidemiology to identify potential
novel drugs for treating mood disorders. Importantly, metformin may have utility
in the treatment of mood disorders, warranting future randomized controlled
trials to test its efficacy. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents  |  Abstract  |  Full text

Source: Pharmacopsychiatry - September 28, 2022 Category: Psychiatry Authors: Lake, Jacqueline Bortolasci, Chiara C. Stuart, Amanda L. Pasco, Julie A. Kidnapillai, Srisaiyini Spolding, Briana Truong, Trang T. T. Panizzutti, Bruna Liu, Zoe S. J. Dean, Olivia M. Crowley, Tamsyn Richardson, Mark Kim, Jee Hyun Berk, Michael Williams, L Tags: Original Paper Source Type: research